Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

597
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
597
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

1.6K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K
Modified-Release Drug Delivery Systems: Rate-Programmed I01:22

Modified-Release Drug Delivery Systems: Rate-Programmed I

172
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
172
Regulation of Pulse01:20

Regulation of Pulse

2.4K
Pulse regulation involves physiological mechanisms that ensure adequate blood flow throughout the body. The heartbeat, regulated by the autonomic nervous system, is influenced by hormonal balance, physical activity, and emotional state.
2.4K
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

1.7K
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
1.7K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of patent foramen ovale on transvenous lead extraction characteristics and outcomes.

Heart rhythm O2·2026
Same author

Contained pulmonary vein injury presenting as a hemorrhagic bulla post-pulsed field ablation: A case report.

HeartRhythm case reports·2026
Same author

Measuring Changes With Pacing Modes: A Closer Look at Clinical Endpoints.

Journal of the American College of Cardiology·2026
Same author

Scope and Outcome of Early Repolarization Syndrome in Unexplained Cardiac Arrest: Insights From the National HiRO Registry.

Circulation. Arrhythmia and electrophysiology·2026
Same author

Initial experience of atrial helix-fixation leadless pacemakers with extended battery longevity.

Heart rhythm·2026
Same author

Editorial: The role of device standards in ensuring safety of patients with cardiac implantable electronic devices undergoing catheter ablation.

Heart rhythm·2026
Same journal

High Rates of Permanent Pacemaker Implantation After Left-Sided Cardiac Surgery in Adults with Congenital Heart Disease.

Heart rhythm·2026
Same journal

Conduction system pacing versus biventricular pacing for cardiac resynchronization therapy: frequentist and bayesian meta-analysis of randomized controlled trial and propensity matched studies.

Heart rhythm·2026
Same journal

Take a Chance? Stroke Risk Management After Atrial Fibrillation Ablation.

Heart rhythm·2026
Same journal

Prominent T-wave induced by Valsalva maneuver associated with a RYR2 loss-of-function variant.

Heart rhythm·2026
Same journal

Management of Engraftment Arrhythmias Associated with Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Transplantation.

Heart rhythm·2026
Same journal

Catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy after septal myectomy.

Heart rhythm·2026
See all related articles

Related Experiment Video

Updated: May 1, 2026

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts
08:43

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts

Published on: August 26, 2021

2.2K

Improved implantable cardioverter-defibrillator shock efficacy using programmable pulse width.

Michael S Katcher1, Kevin Davis2, Nima Badie2

  • 1Mass General Brigham-Salem Hospital, Salem, Massachusetts.

Heart Rhythm
|April 29, 2026
PubMed
Summary
This summary is machine-generated.

Fixed pulse width waveforms significantly improve implantable cardioverter-defibrillator (ICD) shock success compared to fixed tilt. This reprogramming enhances first-shock success rates for treating ventricular tachycardia/fibrillation (VT/VF).

Keywords:
Fixed pulse widthFixed tiltImplantable cardioverter-defibrillatorShock programmingShocks

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

2.8K
Bidirectional Electrical and Optoelectronic Interfaces in Healthy and Ischemic Ex Vivo Rat Hearts
08:33

Bidirectional Electrical and Optoelectronic Interfaces in Healthy and Ischemic Ex Vivo Rat Hearts

Published on: July 18, 2025

1.0K

Related Experiment Videos

Last Updated: May 1, 2026

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts
08:43

Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts

Published on: August 26, 2021

2.2K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

2.8K
Bidirectional Electrical and Optoelectronic Interfaces in Healthy and Ischemic Ex Vivo Rat Hearts
08:33

Bidirectional Electrical and Optoelectronic Interfaces in Healthy and Ischemic Ex Vivo Rat Hearts

Published on: July 18, 2025

1.0K

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Medical Devices

Background:

  • Implantable cardioverter-defibrillator (ICD) shock waveforms are defined by tilt or pulse width.
  • Current ICD programming often relies on fixed tilt, but fixed pulse width may enhance shock efficacy.
  • Optimizing ICD shock waveforms is crucial for successful treatment of life-threatening arrhythmias.

Purpose of the Study:

  • To compare shock energies and success rates between fixed pulse width and fixed tilt waveforms.
  • To evaluate the efficacy of different ICD/CRT-D shock waveform programming strategies for spontaneous ventricular tachycardia/fibrillation (VT/VF).

Main Methods:

  • Retrospective analysis of US patients with single-coil ICD/CRT-D devices who received shock therapy.
  • Comparison of shock success rates and energies when devices were programmed to both 65% fixed tilt and fixed pulse width modes.
  • Data extracted from the Merlin.net patient remote care network for patient demographics, programming, and shock episodes.

Main Results:

  • Fixed pulse width significantly increased first-shock success rates compared to fixed tilt (100.0% vs. 87.5%, P<0.001).
  • A higher percentage of patients achieved 100% first-shock success with fixed pulse width (69.3% vs. 46.2%, P<0.001).
  • Comparable shock energies were delivered between the two waveform types (33.0 J vs. 32.9 J, P=0.53).

Conclusions:

  • Reprogramming ICD shock waveforms from fixed tilt to fixed pulse width significantly improves intra-patient shock success.
  • Fixed pulse width represents a superior programming strategy for enhancing defibrillation efficacy in ICD/CRT-D devices.